Vascular endothelial growth factor and endometriotic angiogenesis

Human Reproduction Update

Volumn 6, Issue 1, 2000, Pages 45-55

  McLaren, J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Angiogenesis; Endometriosis; VEGF

Indexed keywords

CELL ADHESION MOLECULE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ENDOMETRIOSIS; FEMALE; HUMAN; PERITONEAL FLUID; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; REVIEW;

EID: 0033951280     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/6.1.45     Document Type: Review

References (126)

1. Achen, M.G., Jeltsch, M., Kukk, K. et al. (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flt-4) Proc. Natl Acad. Sci. USA, 95, 548-553.
2. Adamis, A.P., Miller, J.W., Bernal, M.T. et al. (1994) Increased vascualr endothelial growth factor levels in the vitreous proliferative diabetic retinopathy. Am. J. Opthalmol., 118, 445-450.
3. Akoum, A., Lemay, A. and Brunet, C. (1995) Cytokine-induced secretion of monocyte chemotactic protein-1 by human endometriotic cells in culture. The groupe d'investigation en gynecologies. Am. J. Obstet. Gynecol., 172, 594-600.
4. Asano, A., Yukita, A., Matsumoto, T. et al. (1995) Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121. Cancer Res., 55, 5296-5301.
5. Asano, M., Yukita, A. and Suzuki, H. (1999) Wide spectrum of a ntitumor activity of a neutralising monoclonal antibody to human vascular endothelial growth factor. Jap. J. Cancer Res., 90, 93-100.
6. Auger, M.J. and Ross, J.A. (1992) The biology of the macrophage. In Lewis, C.E. and McGee, J.O.D. (eds), The Macrophage. IRL Press, Oxford, UK, pp. 1-74.
7. Ausprunk, D.H., Knighton, D.R. and Folkman, J. (1974) Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev. Biol., 38, 237-248.
8. Benjamin, L.E. and Keshet, C. (1997) Conditional switching of vascular endothelial growth factor (VEGF) expression in tumours: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl Acad. Sci. USA, 94, 8761-8766.
9. Bergqvist, A. (1992) Steroid receptors in endometriosis. In Thomas, E. and Rock, J. (eds), Modern Approaches to Endometriosis. Kluwer Academic Publishers Group, Dordrecht, pp. 257-274.
10. Boocock, C.A., Charnock-Jones, D.S., Sharkey, A.M. et al. (1995) Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma. J. Natl Cancer Inst., 87, 506-516.
11. Breier, G., Albrecht, U., Sterrer, S. et al. (1992) Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development, 114, 521-532.
12. Bridges, J.E., Prentice, A. and Roche, W. (1995) Expression of integrin adhesion molecules in endometrium and endometriosis. Br. J. Obstet. Gynaecol., 101, 696-700.
13. Brogstrom, P., Hillan, K.J., Sriramarao, P. et al. (1996) Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibodies. Novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res., 56, 4032-4039.
14. Brooks, P.C., Clark, R.A.F. and Cheresh, D.A. (1994) Requirement of vascular integrin avb3 for angiogenesis. Science, 264, 569-571.
15. Burri, P.H. and Tarek, M.R. (1990) A novel mechanism of capillary growth in the rat pulmonary microcirculation. Anat. Rec., 228, 35-45.
16. Carmeliet, P. and Collen, D. (1998) Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr. Top. Microbiol. Immunol., 237, 133-157.
17. Chao, T.C., Alten, P.J.V., Greager, J.A. et al. (1995) Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. J. Immunol., 154, 1838-1845.
18. Charnock-Jones, D.S., Sharkey, A.M. and Rajput-Williams, J. (1993) Identification and localisation of alternately spliced nRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod., 48, 1120-1128.
19. Charnock-Jones, D.S., Sharkey, A.M. and Boocock, C.A. (1994) Vascular endothelial growth factor localisation and activation in human trophoblast and choriocarcinoma cells. Biol. Reprod., 51, 524-530.
20. Clarke, D.E., Smith, S.K., He, Y. et al. (1998) A vascular endothelial growth factor antagonist is produced by human placenta and released into the maternal circulation. Biol. Reprod., 59, 1540-1548.
21. Clauss, M., Gerlach, M., Gerlach, H. et al. (1990) Vascular permeability factor: a tumor-derived ploypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med., 172, 1535-1545.
22. Cornillie, F.J., Oosterlynck, D. and Leuweryns, J.M. (1990) Deeply infiltrating pelvic endometriosis: histology and clinical significance. Fertil. Steril., 53, 978-983.
23. Cramer, D.W., Wilson, E. and Stillman, R.J. (1986) The relation of endometriosis to menstrual characteristics, smoking and exercise. J. Am. Med. Assoc., 255, 1904-1908.
24. Crystal, R.G. (1999) In vivo and ex vivo gene therapy strategies to treat tumors using adenovirus gene transfer vectors. Cancer Chemother. Pharmacol., 43, S90-S99.
25. Detmar, M., Brown, L.F., Claffey, K.P. et al. (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med., 180, 1141-1146.
26. Donnez, J., Smoes, P., Gillerot, S. et al. (1998) Vascular endothelial growth factor (VEGF) in endometriosis. Hum. Reprod., 13, 1686-1690.
27. Dvorak, H.F., Harvey, V.S., Estrella, P. et al. (1987) Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab. Invest., 57, 673-686.
28. Dvorak, H.F., Brown, L.F., Detmar, M. et al. (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146, 1029-1039.
29. Enholm, B., Paavonen, K., Ristimaki, A. et al. (1997) Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene, 14, 2475-2483.
30. Eriksson, U. and Alitalo, K. (1999) Structure, expression and receptor-binding properties of novel vascular endothelial growth factors. Curr. Top. Microbiol. Immunol., 237, 41-57.
31. Ferrara, N. (1999) Vascular endothelial growth factor: Molecular and biological aspects. Curr. Top. Microbiol. Immunol., 237, 1-30.
32. Ferrara, N. and Davis-Smyth, T. (1997) The biology of vascular endothelial growth factor. Endocr. Rev., 18, 4-25.
33. Folkman, J. and Shing, Y. (1992) Angiogenesis. J. Biol. Chem., 267, 10931-10934.
34. Fong, G.H., Zhang, L., Bryce, D.M. et al. (1999a) Increased hemangioblast commitment, not vascular disorganisation is the primary defect in flt-1 knock-out mice. Development, 126, 3015-3025.
35. Fong, T.A., Shawver, L.K., Sun, L. et al. (1999b) SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (FLK-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularisation, and growth of multiple tumor types. Cancer Res., 59, 99-106.
36. Gabrilovich, D.I., Chen, H.L., Girgis, K.R. et al. (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendrite cells. Nature Med., 2, 1096-1103.
37. Gimmond, S., Lagercrantz, J., Drinkwater, C. et al. (1996) Cloning and characterisation of a novel human gene related to vascular endothelial growth factor. Genome Res., 6, 124-131.
38. Gitay-Goren, H., Halaban, R. and Neufeld, G. (1993) Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. Biochem. Biophys. Res. Commun., 190, 702-708.
39. Goldman, C.K., Kendall, R.L., Cabrera, G. et al. (1998) Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc. Natl Acad. Sci. USA, 95, 8795-8000.
40. Halme, J., Becker, S., Hammond, M.G. et al. (1983) Increased activation of pelvic macrophages in infertile women with mild endometriosis. Am. J. Obstet. Gynecol., 145, 333-337.
41. Halme, J., Hammond, M.G. and Hulka, J.F. (1984) Retrograde menstruation in healthy women and in patients with endometriosis. Obstet. Gynecol., 64, 151-154.
42. Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-364.
43. Healy, D.L., Rogers, P.A.W., Hii, L. et al. (1998) Angiogenesis: a new t heory for endometriosis. Hum. Reprod. Update, 4, 736-740.
44. Hill, J.A. (1992) Immunology and endometriosis. Fertil. Steril., 58, 262-264.
45. Hornung, D., Ryan, I.P., Chao, V.A. et al. (1997) Immunolocalisation and regulation of the chemokine RANTES in human endothelial and endometriosis tissues and cells. J. Clin. Endocrinol. Metab., 82, 1621-1628.
46. Houck, K.A., Ferrara, N., Winer, J. et al. (1991) The vascular endothelial growth factor family: identification of a fourth molecular species and characterisation of alternative splicing of RNA. Mol. Endocrinol., 5, 1806-1814.
47. Jakeman, L., Winer, J., Bennett, G.L. et al. (1992) Binding sites for vascular endothelial growth factor are localised on endothelial in adult rat tissue. J. Clin. Invest., 89, 244-253.
48. Joukov, V., Pajusola, K., Kaipainen, A. et al. (1996) A novel endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J., 15, 290-298.
49. Ke, L.D., Fueyo, J., Chen, X. et al. (1998) A novel approach to glioma gene therapy: down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes. Int. J. Oncol., 12, 1391-1396.
50. Kendall, R.L., Wang, G. and Thomas, K.A. (1996) Identification of a natural soluable form of the vascular endothelial growth factor response, FLT-1 and its heterodimerization with KDR. Biochem. Biophys. Res. Commun., 226, 324-328.
51. Khorram, O., Taylor, R.N. et al. (1993) Peritoneal fluid concentrations of the cytokine rantes correlate with the severity of endometriosis. Am. J. Obstet. Gynecol., 169, 1545-1549.
52. Kim, L.T. and Yamada, K.M. (1997) The regulation of expression of integrin receptors. J. Exp. Biol. Med., 214, 123-131.
53. Kim, K.J., Li, B., Winer, J. et al. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature, 362, 841-844.
54. Koch, A.E., Harlow, L., Haines, G.K. et al. (1994) Vascular endothelial growth factor: a cytokine modulating endothelial fucntion in rheumatoid arthritis. J. Immunol., 152, 4149-4156.
55. Kokorine, I., Nisolle, M. and Donnez, J. (1997) Expression of i nterstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions. Fertil. Steril., 68, 246-251.
56. Koninckx, P.R., Meuleman, C. and Demeyere, S. (1991) Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertil. Steril., 55, 759-765.
57. Koninckx, P.R., Kennedy, S.H. and Barlow, D.H. (1998) Endometriotic disease: the role of peritoneal fluid. Hum. Reprod. Update, 4, 741-751.
58. Krussel, J.S., Casan, E.M., Raga, F., et al. (1999) Expression for mRNA for VEGF transmembraneous receptors Fit-1 and KDR. and the soluble receptor sflt in cycling human endometrium. Mol. Hum. Reprod., 5, 452-458.
59. Kupker, W., Schultze, A. and Diedrich, K. (1998) Paracrine changes in the peritoneal environment of women with endometriosis. Hum. Reprod., 4, 719-723.
60. Lamb, K., Hoffman, R.G. and Nichols, T.R. (1986) Family trait analysis: a case-control study of 43 women with endometriosis and their best friends. Am. J. Obstet. Gynecol., 154, 596-601.
61. Lee, J., Gray, A., Yuan, J. et al. (1996) Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Fit 4. Proc. Natl Acad. Sci. USA, 93, 1988-1992.
62. Leenders, W.P.J. (1998) Targeting VEGF in anti-angiogenic and anti-tumour therapy. Int. J. Exp. Pathol., 79, 339-346.
63. Leung, D.W., Cachianes, G., Kuang, W.J. et al. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306-1309.
64. Li, X.F., Gregory, J. and Ahmed, A. (1994) Immunolocalisation of vascular endothelial growth factor in human endometrium. Growth Factors, 11, 277-282.
65. Lichtenbeld, H.C., Ferarra, N., Jain, R.K. et al. (1999) Effect of local anti-VEGF antibody treatment on tumor microvessel permeability. Microvascular Res., 57, 357-362.
66. Lin, P., Sankar, S., Shan, S. et al. (1998) Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor. Cell Growth Differ., 9, 49-58.
67. Liu, D.T.Y. and Hitchcock, A. (1986) Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology. Br. J. Obstet. Gynaecol., 93, 859-862.
68. Liu, J., Razani, B., Tang, S. et al. (1999) Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1. J. Biol. Chem., 214, 15781-15785.
69. Maglione, D., Guerriero, V., Viglietto, G. et al. (1991) Isolation of a human placenta cDNA encoding for a protein related to the vascular permeability factor. Proc. Natl Acad. Sci. USA, 88, 9267-9271.
70. McLaren, J. and Prentice, A. (1996) New aspects of pathogenesis of endometriosis. Curr. Obstet. Gynaecol., 6, 85-91.
71. McLaren, J., Prentice, A., Charnock-Jones, D.S. et al. (1996a) Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Invest., 98, 482-489.
72. McLaren, J., Prentice, A., Charnock-Jones, D.S. et al. (1996b) Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum. Reprod., 11, 220-223.
73. Melder, R.J., Koenig, G.C., Witwer, B.P. et al. (1996) During angiogenesis vascular endothelial growth factor and basic growth factor r egulate natural killer cell adhesion to tumor endothelium. Nature Med., 2, 992-997.
74. Millauer, B., Lunghi, M.P. and Plate, K.H. (1996) Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res., 56, 1615-1620.
75. Millauer, B., Shawver, L.K., Plate, K.H. et al. (1994) Glioblastoma growth inhibited in vivo by dominant-negative Flk-1 mutant. Nature, 367, 576-579.
76. Mu, J., Abe, Y., Tsutsui, T. et al. (1996) Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity. Jap. J. Cancer. Res., 87, 963-971.
77. Mukhopadhyay, D., Tsokias, L., Zhou, X.-M. et al. (1995) Hypoxic induction of human vascular endothelial growth factor expression through c-SRC activation. Nature, 375, 577-581.
78. Nisolle, M., Casanas-Roux, F., Anaf, V. et al. (1993) Morphometric study of the stromal vascularisation in peritoneal endometriosis. Fertil. Steril., 59, 681-684.
79. Olive, D.L., Montoya, I., Riehl, R.M. et al. (1991) Macrophage conditioned media enhance endometrial stromal cell proliferation in vitro. Am. J. Obstet. Gynecol., 164, 953-958.
80. Olofsson, B., Pajusola, K., euler, G.V. et al. (1996a) Genomic organisation of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterisation of a second splice isoform. J. Biol. Chem., 271, 19310-19317.
81. Olofsson, B., Pajusola, K., Kaipainen, A. et al. (1996b) Vascular endothelial growth factor B a novel growth factor for endothelial cells. Proc. Natl Acad. Sci. USA, 93, 2576-2581.
82. Olson, T.A., Mohanraj, D., Carson, L.F. et al. (1994) Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res., 54, 276-280.
83. Oosterlynck, D.J., Cornillie, F.J. and Waer, M. (1991) Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil. Steril., 56, 45-51.
84. Oosterlynck, D.J., Meuleman, C., Sobis, H. et al. (1993) Angiogenic activity of peritoneal fluid from women with endometriosis. Fertil. Steril., 59, 778-782.
85. Orlandini, M., Marconcini, L., Feruzzi, R. et al. (1996) Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/ vascular endothelial growth factor family. Proc. Natl Acad. Sci. USA, 93, 11675-11680.
86. Osteen, K.G., Rodgers, W.H. and Gaire, M. (1994) Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc. Natl Acad. Sci. USA, 91, 10129-10133.
87. Pajusola, K., Aprelikova, O., Korhonen, J. et al. (1992) FLT4 receptor tyrosine kinase containes seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res., 52, 5738-5743.
88. Persico, M.G., Vincenti, V. and DiPalma, T. (1999) Structure, expression and receptor binding properties of placental growth factor (PLGF). Curr. Top. Microbiol. Immunol., 237, 39-42.
89. Poltorak, Z., Cohen, T., Sivan, R. et al. (1997) VEGF 145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J. Biol. Chem., 272, 7151-7158.
90. Ramakrishnan, S., Olson, T.A., Bautch, V.L. et al. (1996) Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-postive endothelial cell proliferation in vitro and angiogenesis in vivo. Cancer Res., 56, 1324-1330.
91. Ramey, J.W. and Archer, D.F. (1993) Peritoneal fluid: its relevance to the development of endometriosis. Fertil. Steril., 60, 1-14.
92. Ravindranath, N., Little-Ihrig, L., Phillips, H.S. et al. (1991) Vascular endothelial factor messenger ribonucleic acid expression in the primate ovary. Endocrinology, 131, 254-260.
93. Rawdanowicz, T.J., Hampton, A.L. and Nagase, H. (1994) Matrix metalloproteinase production by cultured human endometrial stromal cells: identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha. J. Clin. Endocrinol. Metab., 79, 530-536.
94. Regidor, P.A., Vogal, C., Regidor, M. et al. (1998) Expression pattern of integrin adhesion molecules in endometriosis and human endometrium. Hum. Reprod. Update, 4, 710-718.
95. Ristimaki, A., Narko, K., Enholm, B. et al. (1998) Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J. Biol. Chem., 273, 8413-8418.
96. Rodgers, W.H., Matrisian, L.M. and Giudice, L.C. (1994) Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J. Clin. Invest., 94, 946-953.
97. Rogers, P.A.W., Lederman, F. and Taylor, N. (1998) Endometrial microvascular growth in normal and dysfunctional states. Hum. Reprod. Update, 4, 503-508.
98. Saito, T., Mizumoto, K. and Kuroki, K. (1995) Expression of MMP3 and TIMP-1 in the endometriosis and the influence of danazol. Acta Obstet. Gynaecol. Jpn., 47, 495-496.
99. Salamonsen, L.A. (1999) Role of proteases in implantation. Rev. Reprod., 4, 11-22.
100. Saleh, M., Stacker, S.A. and Wilks, A.F. (1996) Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res., 56, 393-401.
101. Sampson, J.A. (1927) Peritoneal endometriosis due to dissemination of endometrial tissue into the peritoneal cavity. Am. J. Obstet. Gynecol., 14, 422-469.
102. 3 integrin complex on human microvascular endothelial cells. J. Invest. Dermatol., 103, 295-299.
103. Shaw, R.W. (1993) An Atlas of Endometriosis. Parthenon Publishing Group, Carnforth, UK.
104. Shen, H., Clauss, M., Ryan, J. et al. (1993) Characterisation of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood, 81, 2767-2773.
105. Shibuya, M., Yamaguchi, S., Yamane, A. et al. (1990) Nuleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene, 5, 519-524.
106. Shibuya, M., Ito, N. and Claesson-Welsh, L. (1999) Structure and fucntion of vascular endothelial growth factor receptor-1 and -2. Curr. Top. Microbiol. Immunol., 237, 59-83.
107. Shifren, J.L., Tseng, J.T., Zaloudek, C.L. et al. (1996) Ovarian steriod regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab., 81, 3112-3118.
108. Sillem, M., Prifti, S., Neher, M. et al. (1998) Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis. Hum. Reprod. Update, 4, 730-735.
109. Smith, S.K. (1998) Angiogenesis, vascular endothelial growth factor and the endometrium. Hum. Reprod. Update, 4, 509-519.
110. Spuijbroek, M.D.E.H., Dunselman, G.A.J. and Menheere, P.P.C.A. (1991) Early endometriosis invades the extracellular matrix. Fertil. Steril., 58, 929-933.
111. Strathy, J.H., Molgaard, C.A. and Coulman, C.B. (1982) Endometriosis and infertility: a laparoscopic study of endometriosis among fertile and infertile women. Fertil. Steril., 38, 667-672.
112. Sunderkotter, C., Steinbrink, K., Goebeler, M. et al. (1994) Macrophages and angiogenesis. J. Leuocyt. Biol., 55, 410-422.
113. Taipale, J., Makinen, T., Arighi, E. et al. (1999) Vascular endothelial growth factor receptor-3. Curr. Top. Microbiol. Immunol., 237, 85-96.
114. Takahashi, Y., Kitadai, Y., Bucana, C. et al. (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55, 3964-3968.
115. Terman, B.I., Dougher-Vermazen, M., Carrion, M.E. et al. (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem. Biophys. Res. Commun., 187, 1579-1586.
116. Thomas, E.J. and Prentice, A. (1992) The aetiology and pathogenesis of endometriosis. Reprod. Med. Rev., 1, 21-36.
117. Tischer, E., Mitchell, R., Hartmen, T. et al. (1991) The human gene for vascular endothelial growth factor, multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem., 266, 11947-11954.
118. Torry, D.S. and Torry, R.J. (1997) Angiogenesis and the expression of vascular endothelial growth factor expression in endometrium and placenta. Am. J. Reprod. Immunol., 37, 21-29.
119. Tsaltas, J., Rogers, P.A.W., Gargett, C. et al. (1998) Excessive angiogenesis: a new theory for endometriosis. Curr. Obstet. Gynaecol., 8, 186-190.
120. Van den Linden, P.J.Q., de Goeij, A.F.P.M. and Dunselman, G.A.J. (1994) Expression of integrins and E-cadherin in cells from menstrual effluent, endometrium, peritoneal fluid, peritoneum, and endometriosis. Fertil. Steril., 61, 85-90.
121. Van den Linden, P.J.Q., de Goeij, A.F.P.M. and Dunselman, G.A.J. (1995) Expression of cadherins and integrins in human endometrium throughout the menstrual cycle. Fertil. Steril., 63, 1210-1215.
122. Viglietto, G., Romano, A., Maglione, D. et al. (1996) Neovascularisation in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not placenta-derived growth factor. Oncogene, 13, 577-587.
123. Vincenti, V., Cassano, C., Rocchi, M. et al. (1996) Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation, 93, 1493-1495.
124. Vries, C.D., Escobedo, J.A., Ueno, H. et al. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science, 255, 989-991.
125. Weil, S.J., Wang, S.Y. and Perez, M.C. (1997) Chemotaxis of macrophages by a peritoneal fluid protein in women with endometriosis. Fertil. Steril., 67, 865-869.
126. Wingfield, M., Macpherson, A., Healy, D.L. et al. (1995) Cell proliferation is increased in the endometrium of women with endometriosis. Fertil. Steril., 64, 340-346.